Recombinant Human E3 Protein，His

E3 ligases, a crucial component of the ubiquitin-proteasome system, play a significant role in post-translational modifications by catalyzing the transfer of ubiquitin to target proteins, thus regulating their stability, localization, and activity. The diversity and specificity of E3 ligases, with hundreds of distinct types identified in humans, enable them to facilitate the degradation of various substrates involved in key cellular processes. Research on E3 ligases has gained momentum due to their involvement in numerous diseases, including cancer, neurodegenerative disorders, and infectious diseases. The ability of E3 ligases to modulate protein levels presents opportunities for therapeutic interventions, as manipulating their activity could restore normal cellular functions or target specific disease-causing proteins for degradation. Recent advancements in structural biology and proteomics have provided insights into the mechanisms by which E3 ligases recognize their substrates, enhancing our understanding of their roles in cellular homeostasis and disease progression. Furthermore, the development of small molecules or peptides that can inhibit or enhance E3 ligase activity is an emerging area of drug development, holding promise for innovative treatment strategies. Consequently, ongoing research into E3 ligases not only deepens our understanding of fundamental biological processes but also paves the way for novel therapeutic approaches in treating diverse diseases.